This report examines how new technologies can emerge in the face of economic pressures that may affect the demand for nuclear imaging, and how healthcare reforms are impacting nuclear medicine. The advent of hybrid imaging has enabled PET/CT imaging to […]
December 2014 Life Science Industry Research Reports
PharmaPoint: Irritable Bowel Syndrome – Global Drug Forecast and Market Analysis to 2023
PharmaPoint: Irritable Bowel Syndrome – Global Drug Forecast and Market Analysis to 2023 Summary Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with altered bowel function. Although IBS is not a life-threatening disorder, it has […]
PharmaPoint: Rheumatoid Arthritis – Global Drug Forecast and Market Analysis to 2023
Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints . It affects over seven million individuals in the 10MM covered in this report (US, France, Germany, Italy, Spain, UK, Japan, Australia, China, and […]
Tenapanor (Irritable Bowel Syndrome) – Forecast and Market Analysis to 2023
Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with altered bowel function. Although IBS is not a life-threatening disorder, it has a considerable effect on patients’ quality of life (QOL). In terms of volume, the […]
Plecanatide (Irritable Bowel Syndrome) – Forecast and Market Analysis to 2023
Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with altered bowel function. Although IBS is not a life-threatening disorder, it has a considerable effect on patients’ quality of life (QOL). In terms of volume, the […]
Xifaxan (Irritable Bowel Syndrome) – Forecast and Market Analysis to 2023
Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with altered bowel function. Although IBS is not a life-threatening disorder, it has a considerable effect on patients’ quality of life (QOL). In terms of volume, the […]
Ibodutant (Irritable Bowel Syndrome) – Forecast and Market Analysis to 2023
Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with altered bowel function. Although IBS is not a life-threatening disorder, it has a considerable effect on patients’ quality of life (QOL). In terms of volume, the […]
Eluxadoline (Irritable Bowel Syndrome) – Forecast and Market Analysis to 2023
Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with altered bowel function. Although IBS is not a life-threatening disorder, it has a considerable effect on patients’ quality of life (QOL). In terms of volume, the […]
Irribow (Irritable Bowel Syndrome) – Forecast and Market Analysis to 2023
Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with altered bowel function. Although IBS is not a life-threatening disorder, it has a considerable effect on patients’ quality of life (QOL). In terms of volume, the […]
Lotronex (Irritable Bowel Syndrome) – Forecast and Market Analysis to 2023
Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with altered bowel function. Although IBS is not a life-threatening disorder, it has a considerable effect on patients’ quality of life (QOL). In terms of volume, the […]
Stay In Touch